SBI General InsuranceUnlisted Shares
₹ 1,150▲0.00%(0.00)
About the company
SBI General Insurance is one of India's leading general insurance companies, offering a comprehensive range of insurance solutions for individuals, families, and businesses. Established in 2009, the company was initially formed as a joint venture between the State Bank of India (SBI) and Insurance Australia Group (IAG). Following IAG's complete exit in 2019, SBI General Insurance has continued to strengthen its position as a trusted provider of non-life insurance products across the country.
The company offers a diverse portfolio of insurance products, including health insurance, motor insurance, home insurance, travel insurance, personal accident insurance, and commercial insurance solutions. These products are designed to provide financial protection against unexpected risks while meeting the evolving needs of customers from different segments.
Fundamentals
Valuation
- 52 week high
- —
- 52 week low
- —
- P/B ratio
- 4.97
- ROE (%)
- 10.67%
- Book value
- ₹231.56
- Face value
- ₹10
- Valuation
- —
Registry
- ISIN number
- INE01MM01017
Figures in cr ·
Financials
| P&L Statement | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| PBT | 718 | 178 | 244 | 318 | 676 | 719 |
| PAT | 543 | 131 | 184 | 239 | 509 | 553 |
| EPS | 25.2 | 6.08 | 8.53 | 10.7 | 22.75 | 24.7 |
Shareholding Pattern
Leadership
| Name | Role | Experience | |
|---|---|---|---|
| Dinesh Kumar Khara | Chairman | 35 yrs experience | — |
| Kishore K. Poludasu | MD & CEO | 32 yrs experience |
Frequently asked questions
Common questions on SBI General Insurance Unlisted Shares—tap a row to read the answer.
Q.1What are SBI General Insurance unlisted shares?
SBI General Insurance unlisted shares are equity shares of the company that are not traded on any recognized stock exchange. These shares are exchanged through private, off-market transactions between buyers and sellers. Investors interested in the company's long-term growth often consider unlisted shares as part of a diversified investment portfolio.
Q.2How can I buy SBI General Insurance unlisted shares?
To buy SBI General Insurance unlisted shares, you need an active Demat account and access to a seller offering the shares. After both parties agree on the price and quantity, the transaction is completed through an off-market transfer, and the shares are credited directly to your Demat account once all documentation and payment formalities are completed.
Q.3Is investing in SBI General Insurance unlisted shares legal in India?
Yes. Investing in SBI General Insurance unlisted shares is legal in India, provided the transaction complies with applicable regulations. The shares should be transferred through authorized depository participants, and all documentation should be completed accurately to ensure a valid and secure transaction.
Q.4Do I need a Demat account to hold SBI General Insurance unlisted shares?
Yes. A Demat account is required to receive, hold, and transfer unlisted shares electronically. It serves as the official record of ownership and enables seamless off-market transfers whenever you decide to buy or sell your shares.
Q.5. What is the minimum investment required for SBI General Insurance unlisted shares?
There is no fixed minimum investment specified by the company. The investment amount depends on factors such as the current market price, availability of shares, transaction size, and the seller's terms. Investors can determine their investment based on their financial goals and risk tolerance.
Q.6Is there a lock-in period after purchasing SBI General Insurance unlisted shares?
In most off-market transactions, there is no mandatory lock-in period simply for purchasing unlisted shares. However, if the company is listed in the future, certain regulatory lock-in requirements may apply to specific shareholders in accordance with prevailing SEBI guidelines.
Trending shares
High-demand unlisted opportunities currently available for trade.
From the blog
Notes on unlisted markets, execution hygiene, and how we think about risk—no hype, no ticker spam.

APTUS PHARMA IPO
Aptus Pharma Limited rolled out its 100% book-built BSE SME public offering worth ₹13.02 Crore. Review crucial parameters for retail investors, featuring the ₹65–₹70 price band, working capital allocations, and an evaluation of its contract-manufacturing partner model.

NEPHROPLUS (NEPHROCARE HEALTH SERVICES) IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

APOLLO TECHNO INDUSTRIES IPO
Apollo Techno Industries Limited has announced its public offering details. Explore the essential investment parameters for retail and institutional bidders, highlighting the fixed price band, lot structure, key market deadlines, and an overview of its industrial manufacturing footprint.

NEOCHEM BIO IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

ANONDITA MEDICARE IPO
Anondita Medicare Limited rolled out its 100% book-built SME public offering worth ₹69.50 Crore on the NSE SME platform. Dig into the critical parameters for investors, highlighting the ₹137–₹145 price band, key working capital objectives, and an analysis of its flagship brand 'COBRA' within the growing sexual wellness market.

NEPTUNE LOGITEK IPO
Explore the Neptune Logitek IPO, including issue details, business strengths, risks, and investment analysis.
